Masoud Maher
- SEC CIK
- 0001874571
No open-market purchases or sales filed in the past year.
Current role at each company
- MXCT Maxcyte, Inc.President and CEOas of Mar 31, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Masoud Maher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 (view filing) | Aug 13 | Same day | Masoud MaherPresident and CEO | PPurchase | +75.0K | $1.37 | +$102.8K | +75.0%175.0K after | |
| Jun 10, 2024 (view filing) | Jun 7-10 | 3 days | Masoud MaherPresident and CEO | PPurchase | +100.0K | $4.89 | +$489.1K | New position100.0K after | 2 lots |
| Nov 16, 2021 (view filing) | Nov 12-16 | 4 days | Masoud MaherEVP and General Counsel | SSale | −75.0K | $12.31 | −$923.4K | −100.0%0 after | 3 lots |